Top Markets
#1 Gama Token Gama Token +8.47%
#2 Audiera Audiera +4.73%
#3 Cross Cross +4.30%
#4 Palladium Network Palladium Network +3.83%
#5 Ontology Gas Ontology Gas +3.45%
#6 Akedo Akedo +3.26%
#7 Ribbita by Virtuals Ribbita by Virtuals +3.05%
#8 Holoworld Holoworld +2.58%
#9 OKZOO OKZOO +2.40%
#10 Tutorial Tutorial +2.30%
Coin of the day
Gama Token Gama Token
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Delota Corp. Delota Corp.

Delota Corp.

SYDRF
Clasificación en acciones #36225
Delota Corp. operates as a Canadian retail company, primarily focusing on the... Delota Corp. operates as a Canadian retail company, primarily focusing on the sale of diverse cannabis products. Their product range also encompasses various vaping and nicotine-related items, herbal vaporizers, and other smoking cessation solutions, along with their complementary accessories. The firm manages a network of 26 brick-and-mortar retail establishments complemented by an online e-commerce platform. These operations are conducted under its two prominent brands: 180 Smoke and Offside Cannabis. The company, which is headquartered in Concord, Canada, transitioned its name to Delota Corp. in November 2021, having previously been recognized as Spyder Cannabis Inc.
Precio por acción
$0.1
Última sincronización: 2026-08-13
Capitalización bursátil
$2.91M
Cambio (1 día)
0.00%
Cambio (1 año)
25.00%
País
CA
Comercio Delota Corp. (SYDRF)

Categoría

Healthcare
Ganancias de Delota Corp. (SYDRF)
Ganancias en 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di Delota Corp., gli utili attuali della società sono 0. Nel 2026, la società ha registrato un utile di 0, igual a agli utili del 2026, che erano di 0. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Historial de ganancias de Delota Corp. desde 2026 hasta 2026
Ganancias al final de cada año
Año Ganancias Cambiar
Not enough data for the provided dates.
Ganancias de empresas similares o competidoras
Empresa Ganancias Diferencia de ganancias País
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
$1.35B -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
- -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
- -
FR
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
- -
IT
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
$26.37M -
US